Bio-Techne Corporation (NASDAQ:TECH) Q2 2026 Earnings Call Transcript February 4, 2026 Bio-Techne Corporation beats earnings ...

Founded in 2021, Colossal is best known for its controversial quest to revive extinct creatures such as the woolly mammoth, ...

Shortly after acquiring Elektrofi to beef up its subcutaneous drug-delivery offerings, Halozyme Therapeutics has struck ...

In a significant move bridging traditional Japanese craftsmanship with Southeast Asian deep-tech innovation, Dr. Kengo Suzuki, President of Tsunan Sake Brewery (Headquarters: Tsunan, Niigata) and CEO ...

Bio-inspired medical devices can gather more data than ever before, and HPC/quantum will massively speed up discovery rates; consumer self-testing will be slower.

Outsourcing is driving biopharma efficiency and scale, including in the drug discovery area and early phase development.

Artificial intelligence is moving quickly into drug discovery as pharmaceutical and biotech companies look for ways to cut years off R&D timelines and increase the chances of success amid rising costs ...

Amid the surging wave of innovation in China's biopharmaceutical industry, a decade is long enough to witness the full evolution of a sector-from its initial emergence and growth to fundamental ...

A Russian start-up company has developed technology to control the brains of birds and it could be used for warfare, an ...

Pat Mahomes and Randi Martin welcomed their son Patrick in 1995 ...

Cantai launched in 2023 with a $3 million seed round. The company has raised $6.55 million to date at an undisclosed valuation, according to PitchBook. It develops drug candidates with special ...